CoChat

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study

Douglas, Nicholas M., Poespoprodjo, Jeanne Rini, Patriani, Dewi, Malloy, Michael J., Kenangalem, Enny, Sugiarto, Paulus, Simpson, Julie A., Soenarto, Yati, Anstey, Nicholas M., Price, Ric N. · 2017 · PLOS Medicine
Cited by 107

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002379

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. K Thriemer, 2017, Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group, Malar J, 16, 141, 10.1186/s12936-017-1784-1 · DOI · Paper page
  2. JK Baird, 2004, Primaquine therapy for malaria, Clin Infect Dis, 39, 1336, 10.1086/424663 · DOI · Paper page
  3. GK John, 2012, Primaquine radical cure of Plasmodium vivax: a critical review of the literature, Malar J, 11, 280, 10.1186/1475-2875-11-280 · DOI · Paper page
  4. W Maneeboonyang, 2011, Directly observed therapy with primaquine to reduce the recurrence rate of Plasmodium vivax infection along the Thai-Myanmar border, Southeast Asian J Trop Med Public Health, 42, 9
  5. KP Grietens, 2010, Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon, Am J Trop Med Hyg, 82, 1017, 10.4269/ajtmh.2010.09-0521 · DOI
  6. R Takeuchi, 2010, Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border, Malar J, 9, 308, 10.1186/1475-2875-9-308 · DOI
  7. T Leslie, 2004, Compliance with 14-day primaquine therapy for radical cure of vivax malaria: a randomized placebo-controlled trial comparing unsupervised with supervised treatment, Trans R Soc Trop Med Hyg, 98, 168, 10.1016/S0035-9203(03)00041-5 · DOI · Paper page
  8. L von Seidlein, 2013, Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report, Malar J, 12, 112, 10.1186/1475-2875-12-112 · DOI · Paper page
  9. NM Anstey, 2012, Plasmodium vivax: Clinical Spectrum, Risk Factors and Pathogenesis, Adv Parasitol, 80, 151, 10.1016/B978-0-12-397900-1.00003-7 · DOI · Paper page
  10. NM Douglas, 2012, The anaemia of Plasmodium vivax malaria, Malar J, 11, 135, 10.1186/1475-2875-11-135 · DOI · Paper page
  11. NM Douglas, 2013, Major burden of severe anemia from non-falciparum malaria species in southern papua: a hospital-based surveillance study, PLoS Med, 10, e1001575, 10.1371/journal.pmed.1001575 · DOI · Paper page
  12. E Tjitra, 2008, Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia, PLoS Med, 5, e128, 10.1371/journal.pmed.0050128 · DOI · Paper page
  13. M Karyana, 2008, Epidemiology of multidrug resistant P. vivax and P. falciparum infection in Southern Papua, Indonesia, Malar J, 7, 148, 10.1186/1475-2875-7-148 · DOI
  14. Z Pava, 2016, Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia, PLoS ONE, 11, e0165340, 10.1371/journal.pone.0165340 · DOI
  15. A Ratcliff, 2007, Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison, Lancet, 369, 757, 10.1016/S0140-6736(07)60160-3 · DOI · Paper page
  16. KE Battle, 2014, Geographical variation in Plasmodium vivax relapse, Malar J, 13, 144, 10.1186/1475-2875-13-144 · DOI · Paper page
  17. A Ratcliff, 2007, Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in Southern Papua, Indonesia, Trans R Soc Trop Med Hyg, 101, 351, 10.1016/j.trstmh.2006.06.008 · DOI · Paper page
  18. E Tjitra, 2002, Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations, Antimicrob Agents Chemother, 46, 3947, 10.1128/AAC.46.12.3947-3953.2002 · DOI
  19. B Russell, 2008, Determinants of in vitro drug susceptibility testing of Plasmodium vivax, Antimicrob Agents Chemother, 52, 1040, 10.1128/AAC.01334-07 · DOI · Paper page
  20. RN Price, 2009, New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance, Curr Opin Infect Dis, 22, 430, 10.1097/QCO.0b013e32832f14c1 · DOI · Paper page
  21. RA Hutchinson, 2006, Malaria and deaths in the English marshes, Lancet, 367, 1947, 10.1016/S0140-6736(06)68850-8 · DOI
  22. NM Douglas, 2013, Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax, The Journal of infectious diseases
  23. R Noviyanti, 2015, Contrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and Elimination, PLoS Negl Trop Dis, 9, e0003739, 10.1371/journal.pntd.0003739 · DOI
  24. LJ Robinson, 2015, Strategies for Understanding and Reducing the Plasmodium vivax and Plasmodium ovale Hypnozoite Reservoir in Papua New Guinean Children: A Randomised Placebo-Controlled Trial and Mathematical Model, PLoS Med, 12, e1001891, 10.1371/journal.pmed.1001891 · DOI · Paper page
  25. T Abreha, 2017, Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial, PLoS Med, 14, e1002299, 10.1371/journal.pmed.1002299 · DOI · Paper page
  26. JW Bennett, 2013, Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria, The New England journal of medicine, 369, 1381, 10.1056/NEJMc1301936 · DOI · Paper page
  27. LD Bradford, 2002, CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants, Pharmacogenomics, 3, 229, 10.1517/14622416.3.2.229 · DOI · Paper page
  28. WE Collins, 1996, Primaquine resistance in Plasmodium vivax, Am J Trop Med Hyg, 55, 243, 10.4269/ajtmh.1996.55.243 · DOI · Paper page
  29. WC Cooper, 1953, Studies in human malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria, Am J Trop Med Hyg, 2, 949, 10.4269/ajtmh.1953.2.949 · doi:10.4269/ajtmh.1953.2.949
  30. I Sutanto, 2013, Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia, Antimicrob Agents Chemother, 57, 1128, 10.1128/AAC.01879-12 · DOI
  31. PN Newton, 2010, Impact of poor-quality medicines in the 'developing' world, Trends in pharmacological sciences, 31, 99, 10.1016/j.tips.2009.11.005 · DOI · Paper page
  32. I Petralanda, 1995, Quality of antimalarial drugs and resistance to Plasmodium vivax in Amazonian region, Lancet, 345, 1433, 10.1016/S0140-6736(95)92620-8 · doi:10.1016/s0140-6736(95)92620-8
  33. MA Kron, 1996, Substandard primaquine phosphate for US Peace Corps personnel, Lancet, 348, 1453, 10.1016/S0140-6736(04)70101-4 · doi:10.1016/s0140-6736(04)70101-4
  34. JK Baird, 1995, Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia, Am J Trop Med Hyg, 52, 479, 10.4269/ajtmh.1995.52.479 · doi:10.4269/ajtmh.1995.52.479
  35. DJ Fryauff, 1995, Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria, Lancet, 346, 1190, 10.1016/S0140-6736(95)92898-7 · doi:10.1016/s0140-6736(95)92898-7
  36. AR Hasugian, 2007, Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria, Clin Infect Dis, 44, 1067, 10.1086/512677 · DOI · Paper page
  37. MT White, 2014, Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission, Elife, 3
  38. M Tanner, 2015, Malaria eradication and elimination: views on how to translate a vision into reality, BMC Med, 13, 167, 10.1186/s12916-015-0384-6 · DOI · Paper page
  39. A Llanos-Cuentas, 2014, Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study, Lancet, 383, 1049, 10.1016/S0140-6736(13)62568-4 · DOI · Paper page

Cited by

See all 107

Metadata

Authors
Douglas, N. M., Poespoprodjo, J. R., Patriani, D., Malloy, M. J., Kenangalem, E., Sugiarto, P., Simpson, J. A., Soenarto, Y., Anstey, N. M., & Price, R. N.
Venue
PLOS Medicine
Published
2017-08-29
Volume
14
Issue
8
Pages
e1002379
ISSN
1549-1676
Cited by
107
References
1
Language
en
Funders
  • Wellcome Trust (200909, 099875)
  • National Health and Medical Research Council (1042072, 1104975, GNT1037304)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.